Indeed, as shown in Figure 2 and Figure 3, the studies published so far show relatively low variability of NfL levels in both CSF and serum in the groups of interest, with values in the same range in PPD patients and in controls that are much below those observed in FTD patients and with little apparent overlap. The gene discussed is NEFL; the disease is progressive pseudorheumatoid arthropathy of childhood.